We appear to have become accustomed to the phrase ‘no one foresaw this happening’. The term certainly applies to those of us taken by surprise in the early hours of June 24th 2016 when the announcement was made that the UK had voted to leave the EU. Here are the five most read life sciences Brexit news stories on our website in the past year. European Medicines Agency (EMA), with a full-time staff of more than 600, is the largest EU body in Britain and has overseen pan-European drug approvals since 1995 from its headquarters tucked away among global banks in London’s Canary Wharf. The centralised procedure is compulsory for medicinal products manufactured using biotechnological processes, for orphan medicinal products and for human products containing a new active substance, which are intended for the treatment of AIDS, cancer, neurodegenerative disorder or diabetes. Read More Here. Read More Here. Read More Here. Read More Here. Read More Here.